The flip side of performance measures: limiting overtreatment
Arch Intern Med
.
2012 Oct 22;172(19):1512.
doi: 10.1001/archinternmed.2012.4560.
Author
Deborah Grady
PMID:
22965339
DOI:
10.1001/archinternmed.2012.4560
No abstract available
Publication types
Editorial
Comment
MeSH terms
Blood Glucose / metabolism*
Diabetes Complications / prevention & control*
Diabetes Mellitus / diagnosis*
Humans
Program Evaluation*
Quality Improvement*
Substances
Blood Glucose